Follow
Jeremy Shefner
Jeremy Shefner
Verified email at DignityHealth.org
Title
Cited by
Cited by
Year
Electrodiagnostic criteria for diagnosis of ALS
M De Carvalho, R Dengler, A Eisen, JD England, R Kaji, J Kimura, K Mills, ...
Clinical neurophysiology 119 (3), 497-503, 2008
12572008
Fundamentals of sensation and perception
MW Levine, JM Shefner
5511991
A revision of the El Escorial criteria-2015
A Ludolph, V Drory, O Hardiman, I Nakano, J Ravits, W Robberecht, ...
Amyotrophic lateral sclerosis and frontotemporal degeneration 16 (5-6), 291-292, 2015
4762015
A collagen‐based nerve guide conduit for peripheral nerve repair: An electrophysiological study of nerve regeneration in rodents and nonhuman primates
SJ Archibald, C Krarup, J Shefner, ST Li, RD Madison
Journal of Comparative Neurology 306 (4), 685-696, 1991
4621991
Monkey median nerve repaired by nerve graft or collagen nerve guide tube
SJ Archibald, J Shefner, C Krarup, RD Madison
Journal of Neuroscience 15 (5), 4109-4123, 1995
4531995
Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis
S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, ...
New England Journal of Medicine 383 (10), 919-930, 2020
3852020
A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
ALS CNTF Treatment Study Group
Neurology 46 (5), 1244-1244, 1996
3711996
Recovery from paralysis in adult rats using embryonic stem cells
DM Deshpande, YS Kim, T Martinez, J Carmen, S Dike, I Shats, LL Rubin, ...
Annals of neurology 60 (1), 32-44, 2006
3392006
A clinical trial of creatine in ALS
JM Shefner, ME Cudkowicz, D Schoenfeld, T Conrad, J Taft, M Chilton, ...
Neurology 63 (9), 1656-1661, 2004
3362004
A proposal for new diagnostic criteria for ALS
JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ...
Clinical Neurophysiology 131 (8), 2020
3342020
Trial of celecoxib in amyotrophic lateral sclerosis
ME Cudkowicz, JM Shefner, DA Schoenfeld, H Zhang, KI Andreasson, ...
Annals of neurology 60 (1), 22-31, 2006
3322006
A controlled trial of recombinant methionyl human BDNF in ALS
BDNF Study Group (Phase III)
Neurology 52 (7), 1427-1427, 1999
331*1999
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
ME Cudkowicz, LH van den Berg, JM Shefner, H Mitsumoto, JS Mora, ...
The Lancet Neurology 12 (11), 1059-1067, 2013
2572013
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
P Kaufmann, JLP Thompson, G Levy, R Buchsbaum, J Shefner, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
2552009
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
ME Cudkowicz, JM Shefner, DA Schoenfeld, RH Brown Jr, H Johnson, ...
Neurology 61 (4), 456-464, 2003
2522003
Nusinersen in later-onset spinal muscular atrophy: long-term results from the phase 1/2 studies
BT Darras, CA Chiriboga, ST Iannaccone, KJ Swoboda, J Montes, ...
Neurology 92 (21), e2492-e2506, 2019
2362019
Lead exposure and amyotrophic lateral sclerosis
F Kamel, DM Umbach, TL Munsat, JM Shefner, H Hu, DP Sandler
Epidemiology 13 (3), 311-319, 2002
2342002
Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy
JM Shefner, AG Reaume, DG Flood, RW Scott, NW Kowall, RJ Ferrante, ...
Neurology 53 (6), 1239-1239, 1999
2341999
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
ME Cudkowicz, S Titus, M Kearney, H Yu, A Sherman, D Schoenfeld, ...
The Lancet Neurology 13 (11), 1083-1091, 2014
2322014
Motor unit number estimation in human neurological diseases and animal models
JM Shefner
Clinical neurophysiology 112 (6), 955-964, 2001
2092001
The system can't perform the operation now. Try again later.
Articles 1–20